Possibility of treatment modification in patients with ankylosing spondylitis achieved of partial remission on treatment with adalimumab: Real practice data

Objective. To assess the duration of remission or inactive disease status in patients with achieved partial remission due to treatment with adalimumab (ADA) after it discontinuation.Materials and methods. A dynamic observation was conducted of 26 patients with ankylosing spondylitis with partial rem...

Celý popis

Podrobná bibliografie

Hlavní autoři:	A. V. Petrov, Ya. O. Shevnina, A. S. Gaffarova, N. V. Matveeva
Médium:	Artigo
Jazyk:	Russo
Vydáno:	IMA PRESS LLC 2021-01-01
Edice:	Научно-практическая ревматология
Témata:	ankylosing spondylitis partial clinical remission adalimumab asdas-crpindex basdai index
On-line přístup:	https://rsp.mediar-press.net/rsp/article/view/2969
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!